122 related articles for article (PubMed ID: 22253423)
1. Improved insulin sensitivity after long-term treatment with AT1 blockers is not associated with PPARγ target gene regulation.
Müller-Fielitz H; Landolt J; Heidbreder M; Werth S; Vogt FM; Jöhren O; Raasch W
Endocrinology; 2012 Mar; 153(3):1103-15. PubMed ID: 22253423
[TBL] [Abstract][Full Text] [Related]
2. Telmisartan increases localization of glucose transporter 4 to the plasma membrane and increases glucose uptake via peroxisome proliferator-activated receptor γ in 3T3-L1 adipocytes.
Furukawa H; Mawatari K; Koyama K; Yasui S; Morizumi R; Shimohata T; Harada N; Takahashi A; Nakaya Y
Eur J Pharmacol; 2011 Jun; 660(2-3):485-91. PubMed ID: 21514293
[TBL] [Abstract][Full Text] [Related]
3. [Candesartan improves insulin resistance induced by high-fat diet in rats].
Yan WH; Dou JT; Pan CY; Chen K; Wang XM; Ma FL; Yang GQ; Wang XL; Mu YM; Lu JM
Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(38):2695-9. PubMed ID: 19080690
[TBL] [Abstract][Full Text] [Related]
4. PPARgamma-activating angiotensin type-1 receptor blockers induce adiponectin.
Clasen R; Schupp M; Foryst-Ludwig A; Sprang C; Clemenz M; Krikov M; Thöne-Reineke C; Unger T; Kintscher U
Hypertension; 2005 Jul; 46(1):137-43. PubMed ID: 15939809
[TBL] [Abstract][Full Text] [Related]
5. Telmisartan improves insulin resistance and modulates adipose tissue macrophage polarization in high-fat-fed mice.
Fujisaka S; Usui I; Kanatani Y; Ikutani M; Takasaki I; Tsuneyama K; Tabuchi Y; Bukhari A; Yamazaki Y; Suzuki H; Senda S; Aminuddin A; Nagai Y; Takatsu K; Kobayashi M; Tobe K
Endocrinology; 2011 May; 152(5):1789-99. PubMed ID: 21427223
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II receptor blockers downsize adipocytes in spontaneously type 2 diabetic rats with visceral fat obesity.
Mori Y; Itoh Y; Tajima N
Am J Hypertens; 2007 Apr; 20(4):431-6. PubMed ID: 17386352
[TBL] [Abstract][Full Text] [Related]
7. Metabolic effects of telmisartan in spontaneously hypertensive rats.
Li YQ; Ji H; Zhang YH; Ding DY; Ye XL
Naunyn Schmiedebergs Arch Pharmacol; 2006 Jul; 373(4):264-70. PubMed ID: 16715213
[TBL] [Abstract][Full Text] [Related]
8. Distinct properties of telmisartan on agonistic activities for peroxisome proliferator-activated receptor γ among clinically used angiotensin II receptor blockers: drug-target interaction analyses.
Kakuta H; Kurosaki E; Niimi T; Gato K; Kawasaki Y; Suwa A; Honbou K; Yamaguchi T; Okumura H; Sanagi M; Tomura Y; Orita M; Yonemoto T; Masuzaki H
J Pharmacol Exp Ther; 2014 Apr; 349(1):10-20. PubMed ID: 24424487
[TBL] [Abstract][Full Text] [Related]
9. Telmisartan ameliorates hyperglycemia and metabolic profile in nonobese Cohen-Rosenthal diabetic hypertensive rats via peroxisome proliferator activator receptor-gamma activation.
Younis F; Stern N; Limor R; Oron Y; Zangen S; Rosenthal T
Metabolism; 2010 Aug; 59(8):1200-9. PubMed ID: 20070992
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity.
Schupp M; Janke J; Clasen R; Unger T; Kintscher U
Circulation; 2004 May; 109(17):2054-7. PubMed ID: 15117841
[TBL] [Abstract][Full Text] [Related]
11. Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats.
Chung S; Park CW; Shin SJ; Lim JH; Chung HW; Youn DY; Kim HW; Kim BS; Lee JH; Kim GH; Chang YS
Nephrol Dial Transplant; 2010 Feb; 25(2):389-99. PubMed ID: 19749146
[TBL] [Abstract][Full Text] [Related]
12. Azilsartan treatment improves insulin sensitivity in obese spontaneously hypertensive Koletsky rats.
Zhao M; Li Y; Wang J; Ebihara K; Rong X; Hosoda K; Tomita T; Nakao K
Diabetes Obes Metab; 2011 Dec; 13(12):1123-9. PubMed ID: 21749604
[TBL] [Abstract][Full Text] [Related]
13. Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity.
Benson SC; Pershadsingh HA; Ho CI; Chittiboyina A; Desai P; Pravenec M; Qi N; Wang J; Avery MA; Kurtz TW
Hypertension; 2004 May; 43(5):993-1002. PubMed ID: 15007034
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II blockade improves mitochondrial function in spontaneously hypertensive rats.
De Cavanagh EM; Toblli JE; Ferder L; Piotrkowski B; Stella I; Fraga CG; Inserra F
Cell Mol Biol (Noisy-le-grand); 2005 Nov; 51(6):573-8. PubMed ID: 16309582
[TBL] [Abstract][Full Text] [Related]
15. Telmisartan downregulates angiotensin II type 1 receptor through activation of peroxisome proliferator-activated receptor gamma.
Imayama I; Ichiki T; Inanaga K; Ohtsubo H; Fukuyama K; Ono H; Hashiguchi Y; Sunagawa K
Cardiovasc Res; 2006 Oct; 72(1):184-90. PubMed ID: 16938288
[TBL] [Abstract][Full Text] [Related]
16. Long-term angiotensin II AT1 receptor inhibition produces adipose tissue hypotrophy accompanied by increased expression of adiponectin and PPARgamma.
Zorad S; Dou JT; Benicky J; Hutanu D; Tybitanclova K; Zhou J; Saavedra JM
Eur J Pharmacol; 2006 Dec; 552(1-3):112-22. PubMed ID: 17064684
[TBL] [Abstract][Full Text] [Related]
17. Effects of angiotensin II AT1 receptor inhibition and exercise training on insulin action in rats on high-fat diet.
Wang Z; Koike T; Li P; Jiang H; Natsume Y; Mu L; Chen T; Oshida Y
Life Sci; 2012 Feb; 90(9-10):322-7. PubMed ID: 22210187
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II receptor blocker telmisartan prevents new-onset diabetes in pre-diabetes OLETF rats on a high-fat diet: evidence of anti-diabetes action.
Zhao ZQ; Luo R; Li LY; Tian FS; Zheng XL; Xiong HL; Sun LT
Can J Diabetes; 2013 Jun; 37(3):156-68. PubMed ID: 24070838
[TBL] [Abstract][Full Text] [Related]
19. Strong reduction of low-density lipoprotein receptor/apolipoprotein E expressions by telmisartan in cerebral cortex and hippocampus of stroke resistant spontaneously hypertensive rats.
Zhai Y; Yamashita T; Kurata T; Fukui Y; Sato K; Kono S; Liu W; Omote Y; Hishikawa N; Deguchi K; Abe K
J Stroke Cerebrovasc Dis; 2014 Oct; 23(9):2350-61. PubMed ID: 25194744
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic treatment with telmisartan induces tissue-specific gene modulation favoring normal glucose homeostasis in Cohen-Rosenthal diabetic hypertensive rats.
Younis F; Oron Y; Limor R; Stern N; Rosenthal T
Metabolism; 2012 Feb; 61(2):164-74. PubMed ID: 21820685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]